Lupus Trial, Recruiting NCT06631404 Sponsor: Sohag University Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT06631404
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older.
  • You have been diagnosed with Systemic Lupus Erythematosus (SLE or "lupus") based on recognised international classification guidelines, or you are a healthy person being included for comparison purposes.
  • You are able to cooperate and answer questions during the study.
  • You are willing and able to sign a written consent form agreeing to take part.

Who may not be able to join:

  • You have another autoimmune disease (a condition where the immune system attacks the body).
  • You have diabetes.
  • You have high blood pressure (hypertension).
  • You have heart failure.
  • You have a liver disease.
  • You have long-term (chronic) kidney failure.
  • You have a narrowing of the arteries that supply the kidneys (confirm with trial site).
  • You have a blood clot in the veins of the kidneys (confirm with trial site).
  • You have an abnormal connection between an artery and vein inside the kidney (confirm with trial site).
  • You have a condition causing a blockage in the kidneys or urinary system that could affect blood flow measurements in the kidneys (confirm with trial site).
  • You are unable or unwilling to cooperate with the study team.
  • You are unwilling or unable to sign a written consent form.

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01027673294

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
30 October 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

doppler for renal artery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov